ABSTRACT
Background: Globally,the need to address strategies for preventing infections associated with health care has increased worldwide. In the city of Valledupar, Colombia, reports of bacteria resistant to chemical or enzymatic biocides in hospital environments and surfaces are increasingly frequent, evidencing the importance of conducting studies aimed at identifying alternative active ingredients for disinfectant products. Objective: Evaluate the in vitro effectiveness of Neem leaves extract over bacteria strains isolated from different areas and surfaces of a health institution in Valledupar, compared to disinfectants for hospital use, an enzymatic detergent, and a commercial chemical disinfectant. Methods: Biocidal activities on bacteria isolated from hospital surfaces, such as Acinetobacter baumanni, Bacillus subtilis, Enterobacter aerogenes, Staphylococcus aureus, Staphylococcus epidermidis, Micrococcus sp, and Stenotrophomonas maltophilia were analyzed. The Neem leaves extract was evaluated at concentrations of 3, 4, and 5 % for each bacterium during 15-minute contact time, incubated at 37 °C for 18 hours. We compared two antimicrobial chemicals, a disinfectant (based on formaldehyde, cetrimide, and glutaraldehyde), and an enzymatic detergent (based on protease, lipase, and amylase). Results: The aqueous Neem extract did not show significant differences with the other treatments with 99.48 to 100% inhibition against bacteria of the species Acinetobacter baumanni, Enterobacter aerogenes, Staphylococcus aureus,and Micrococcus sp.; Bacillus subtilis, and Stenotrophomonas maltophilia strains were the most resistant strains inhibited by enzymatic detergent and disinfectant, respectively. None of the products evaluated were effective against all in vitro strains. Conclusions: These data show Neem's bacteriostatic properties, its potential in in-hospital products and the need to combine different active ingredients in a disinfection plan.
Antecedentes: A nivel mundial ha aumentado la necesidad de abordar estrategias para la prevención de infecciones asociadas a la atención de salud. En la ciudad de Valledupar, Colombia, cada vez son más frecuentes los reportes de bacterias resistentes a biocidas químicos o enzimáticos, en ambientes y superficies hospitalarias, lo cual evidencia la importancia de realizar estudios orientados a la identificación de principios activos alternativos para productos desinfectantes. Objetivo: Evaluar la efectividad in vitrodel extracto de hojas de Neem en cepas de bacterias aisladas en diferentes áreas y superficies de una institución de salud en Valledupar, en comparación con desinfectantes de uso hospitalario, un detergente enzimático y un desinfectante químico comercial. Métodos: Se analizó la actividad biocida sobre las bacterias aisladas de superficies hospitalarias Acinetobacter baumanni, Bacillus subtilis, Enterobacter aerogenes, Staphylococcus aureus, Staphylococcus epidermidis, Micrococcus sp, y Stenotrophomonas maltophilia. El extracto de hojas de Neem se evaluó a concentraciones de 3, 4 y 5% para cada bacteria durante un tiempo de contacto de 15 minutos, incubados a 37 ° C durante 18 horas. Se comparó dos productos químicos antimicrobianos, un desinfectante (a base de formaldehído, cetrimide y glutaraldehído), y un detergente enzimático (a base de Proteasa, Lipasa y amilasa). Resultados: El extracto acuoso de Neem no presentó diferencias significativas con los demás tratamientos con inhibición del 99,48 al 100%, sobre bacterias de las especies Acinetobacter baumanni, Enterobacter aerogenes, Staphylococcus aureus y Micrococcus sp; las cepas Bacillus subtilisy Stenotrophomonas maltophilia fueron las más resistentes a ser inhibidas por el detergente enzimático y el desinfectante, respectivamente. Ninguno de los productos evaluados fue efectivo contra todas las cepas in vitro. Conclusiones: Estos datos evidencian las propiedades bacteriostáticas del Neem, su potencial en productos de uso intrahospitalario y la necesidad de combinar diferentes principios activos en un plan de desinfección.
Subject(s)
Humans , Anti-Bacterial Agents , Staphylococcus epidermidis , Cross Infection , Acinetobacter baumanniiABSTRACT
O presente trabalho teve como objetivos: a) avaliar a atividade antimicrobiana dos extratos naturais de alecrim, bardana, romã e cavalinha, sobre oito cepas de micro-organismos multirresistentes de Acinetobacter baumanii em cultura planctônica, verificando a concentração inibitória mínima e concentração microbicida mínima (CIM e CMM); b) avaliar a atividade antibiofilme dos extratos que apresentaram atividade antimicrobiana em cultura planctônica sobre cepas multirresistentes de A. baumanii no tempo de 5 minutos; c) avaliar a citotoxicidade das concentrações mais efetivas dos extratos que apresentaram atividade antimicrobiana nos testes em cultura planctônica sobre queratinócitos, em ensaio da atividade mitocondrial celular pelo método MTT, no tempo de 5 minutos. Para a determinação da CIM e CMM dos extratos utilizou-se o método de microdiluição em caldo, segundo Clinical and Laboratory Standards Institute (CLSI), norma M27-A21 (CLSI, 2002) suplementada por M27-S4 (CLSI, 2012). Este teste foi realizado sobre 8 cepas clínicas de Acinetobacter baumanii e 4 extratos, perfazendo 32 grupos experimentais (n=8). Os extratos que apresentaram ação bacteriostática ou bactericida nos testes anteriores foram avaliados sobre biofilmes monomicrobianos (8 cepas clínicas de Acinetobacter baumanii), no tempo de contato de cinco minutos. As concentrações dos extratos, que apresentaram ação anti-biofilme sobre as cepas bacterianas analisadas, foram submetidas à análise de citotoxicidade em queratinócitos humanos. A avaliação foi realizada por meio do teste colorimétrico MTT, que analisou a atividade mitocondrial celular, após contato dos extratos por 5 min. Os resultados foram analisados estatisticamente por ANOVA e Tukey Test, sendo considerada diferença estatística significativa quando p ≤ 0,05. O extrato de romã apresentou CIM e CMM para todas as cepas analisadas, em quanto o extrato de alecrim apresentou CIM e CMM para 6 cepas das 8 analisadas, ambos apresentaram redução de biofilme, entretanto, romã foi o que apresentou as maiores reduções para a maioria das cepas. O extrato de romã apresentou viabilidade celular superior a 80% na maioria das concentrações e o alecrim apresentou viabilidade celular para 5 concentrações das 8 analisadas. Com isso pode-se concluir que o extrato de romã apresentou um melhor resultado comparado aos outros extratos, pois demonstrou uma significativa atividade antimicrobiana e antibiofilme e ausência de toxicidade conforme tempo de aplicação e concentração utilizada contra as cepas clínicas multirresistentes de Acinetobacter baumanni, podendo ser considerado potencial agente terapêutico para o combate destes patógenos(AU)
The objective of the present work was: a) to evaluate the antimicrobial activity of the natural extracts of rosemary, burdock, pomegranate and horsetail on eight strains of multidrug resistant Acinetobacter baumanii microorganisms in planktonic culture, verifying the minimum inhibitory concentration and minimum microbicidal concentration (MIC) and CMM); b) evaluate the antibiofilm activity of extracts that showed antimicrobial activity in planktonic culture on multi-resistant strains of A. baumanii within 5 minutes; c) to evaluate the cytotoxicity of the most effective concentrations of the extracts that showed antimicrobial activity in the tests in planktonic culture on keratinocytes, in an assay of cellular mitochondrial activity by the MTT method, in 5 minutes. For the determination of the minimum inhibitory (MIC) and minimum microbicidal (CMM) concentrations of the extracts, the broth microdilution method according to the Clinical and Laboratory Standards Institute (CLSI), standard M27-A21 (CLSI, 2002) supplemented by M27 was used. -S4 (CLSI, 2012). This test was performed on 8 clinical strains of Acinetobacter baumanii and 4 extracts, making 32 experimental groups (n = 8). The extracts that showed bacteriostatic or bactericidal action in the previous tests were evaluated on monomicrobial biofilms (8 clinical strains of Acinetobacter baumanii) at contact time of 5 minutes. The concentrations of the extracts, which showed anti-biofilm action on the bacterial strains analyzed, were submitted to cytotoxicity analysis in human kerotinocytes. The evaluation was performed by the MTT colorimetric test, which analyzed the mitochondrial cellular activity, after contact of the extracts for 5 min. The results were statistically analyzed by ANOVA and Tukey Test, being considered statistically significant difference when p ≤ 0.05. Pomegranate extract showed MIC and CMM for all strains analyzed, while rosemary extract showed MIC and CMM for 6 strains of the 8 analyzed, both showed reduced biofilm, however, pomegranate was the one that showed the greatest reductions for most of the strains. Pomegranate extract showed cell viability greater than 80% in most concentrations and rosemary showed cell viability for 5 concentrations of the 8 analyzed.Therefore it can be concluded that the pomegranate extract presented a better result compared to the other extracts, since it demonstrated a significant antimicrobial and antibiofilm activity and absence of toxicity according to the time of application and concentration used against the multidrug-resistant clinical strains of Acinetobacter baumanni, which can be considered a potential therapeutic agent to combat these pathogens(AU)
Subject(s)
Plant Extracts/therapeutic use , Acinetobacter baumannii/immunologyABSTRACT
To investigate the distribution of the resistance genes of Acinetobacter baumannii to aminoglycoside,48 strains of extensively drug resistant Acinetobacter baumannii were collected from the First Affiliated Hospital of Bengbu Medical College from January to December,2015.The drug sensitivity test and identification were performed by VITEK 2 compact automatic microorganism instrument.Twelve aminoglycosides modifying enzymes,three 16SrRNA methylase genes and efflux pump abeB gene were detected from these isolates by PCR.Results showed that among these experimental 16 genes,aac(6')-Ⅰb gene was detected from 19 of 48 isolates (39.6％),both armA and adeB genes were 43 (89.6％),ant(3")-Ⅰa gene was from 5 (10.4％),while the other genes were not found.And more than two gene types were amplified from 39 of 48 strains (81.3％).In conclusion,the aac(6')-Ⅰb,armA gene and efflux pump adeB may play a key role in drug resistance to aminoglycosides antibiot ics of Acinetobacter Baumanni in our hospital.
ABSTRACT
Objetivo: Observar el perfil de sensibilidad y resistencia antimicrobiana de Acinetobacter spp., aislado en pacientes hospitalizados en el Hospital Municipal Boliviano Holandés durante el año 2010 al 2014. Material y métodos: Se revisaron un total de 167 cultivos positivos de Acinetobacter spp. Se realizó un estudio observacional no experimental, descriptivo, retrospectivo, de corte transversal. Resultados: En el antibiograma de los cultivos positivos de Acinetobacter spp. se utilizaron ocho antimicrobianos y se identificó la siguiente sensibilidad y resistencia: a) amikacina, sensibilidad de 25%, sensibilidad intermedia de 2% y resistencia 73%; b) ampicilina más sulbactam, sensibilidad de 22%, intermedia de 8% y resistencia 70%; c) ceftazidime, sensibilidad de 9%, intermedia de 4% y resistencia 87%; d) ciprofloxacina sensibilidad 19%, intermedia 1% y resistencia 80%; e) gentamicina, sensibilidad de 21%, intermedia 0% y resistencia 79%; f) SMX-TMP, sensibilidad de 14%, intermedia de 1% y resistencia 85%; g) imipenem sensibilidad de 61%, intermedia de 1% y resistencia 38%; h) meropenem con sensibilidad de 57%, intermedia 4% y resistencia 39%. Se observó una resistencia absoluta a 6 antimicrobianos. La multidrogoresistencia se identificó en el 41%, la misma que se incrementó progresivamente en los últimos años. Así, en el 2010 se encontró solo 3% de multidrogoresistencia, el 2011 6%, el 2012 y 2013 19% y en el año 2014 53%. Conclusiones: La incidencia de infecciones por Acinetobacter spp., un agente nosocomial de gran importancia clínica, se incrementó de manera progresiva en los últimos años en nuestro hospital al igual que su resistencia. Por ello, se aconseja un uso racional de antimicrobianos y mejorar las medidas de bioseguridad en nuestro nosocomio y en el personal de salud.
Objective: To observe the sensitivity profile and antimicrobial resistance of Acinetobacter spp, isolated from patients hospitalized in the Bolivian Dutch Municipal Hospital during 2010 to 2014. Material and Methods: A total of 167 positive cultures of Acinetobacter spp were reviewed a non-experimental, descriptive, retrospective, observational cross-sectional study was conducted. Results: In the susceptibility testing of positive cultures of Acinetobacter spp. eight antimicrobials were used and the following sensitivity and resistance was identified: a) amikacin, sensitivity of 25%, 2% intermediate sensitivity and resistance 73%; b) ampicillin-sulbactam, sensitivity of 22%, 8% and intermediate resistance 70%; c) ceftazidime, sensitivity of 9%, 4% and intermediate resistance 87%; d) Ciprofloxacin sensitivity 19%, 1% and intermediate resistance 80%; e) gentamicin, sensitivity of 21%, intermediate resistance 0% and resistance 79%; f) TMP-SMX, sensitivity of 14%, intermediate 1% and resistance 85%; g) 61% sensitivity imipenem, intermediate 1% and resistance 38%; h) meropenem with sensitivity of 57%, intermediate resistance and 4% resistance 39%, absolute resistance to 6 antimicrobials was observed. multidrug resistense identified in 41%, the same as it was progressively increased in recentyears. Thus, in 2010 he found only 3% of multidrug, 6% in 2011,2012 and 2013 19% and in 2014 53%. Conclusions. The incidence of infections Acinetobacter spp, a nosocomial agent of great clinical importance, gradually increased in recent years in our hospital as their resistance. Therefore, it is advisable rational use of antimicrobials and improves bio-security measures in our hospital and health personnel.
ABSTRACT
Objective:To discuss the results interpretation and clinical significance of Acinetobacter Baumanni ( AB) positive spu-tum samples .Methods:The anti-infection treatment of one patient with lung infection after colon cancer surgery in ICU was analyzed , and the results interpretation and clinical significance of AB positive sputum samples were discussed .Results:Although the culture re-sults of sputum samples were positive , the quality of sputum samples was low and the credibility was poor .The possibility of multiple drug resistance AB ( XDR-AB) screened by antibiotics selective stress was small .Meanwhile, the clinical infection symptoms were mild, and the treatment with imipenem was effective .Although the patient had high risk factors for the colonization of Baumanni infec-tion, XDR-AB was not a pathogen .Conclusion:When respiratory samples are AB positive , the quality of samples should be evaluated by smear results firstly , especially the existence of white blood cell phagocytosis or accompanying should be paid attention to , and then the possibility of AB screened by antibiotics selective stress and high risk factors for colonization should be analyzed .Finally, combined with the clinical symptoms of patients and the treatment efficacy before drug sensitivity tests , whether XDR-AB is pathogenic bacteria should be judged , and then the corresponding anti-infection treatment plan should be determined .
ABSTRACT
Objective To analyze antibacterial resistance and distribution of Acinetobacter baumanni in clinical departments,in order to provide references for hospital infection control.Methods Clinical isolates of Acinetobacter baumanni from January 2012 to July 2014 were collected.Bacterial identification and antibacterial susceptibility tests were carried out by using the VITEK 2 Compact automatic bacterial identification system,and results of resistance of Acinetobacter baumanni were analysed by using the WHONET5.0 software.Results A total of 285 strains of Acinetobacter baumanni were isolated and mainly were isolated from the intensive care unit(ICU)(accounted for 47.0%),most of the infected patients were male,and patients aged 45 years and over ac-counted for 70.5%.The resistance rate of aztreonam against Acinetobacter baumanni(71.9%)was the highest and the lowest was levofloxacin(25.7%).The resistance rates of most of antibacterials tested in this study were approximately 50%,and resistance rates of piperacillin-tazobactam and imipenem was approaching 40%.Conclusion Strains of Acinetobacter baumannii are mainly i-solated from ICU and antibacterial resistance of isolates is serious.Hospitals should strengthen infection control and promote ra-tional use of antibacterials according to results of antibacterial-susceptibility test,so as to reduce antibacterial resistance.
ABSTRACT
Objective To identify strains of Acinetobacter(A.)calcoaceticus-A.baumannii complex accurately,and investigate the species distribution of Acinetobacter calcoaceticus-A.baurnannii(ACB)complex isolated in Daping Hospital.Analysis the anti-biotics resistance of ACB complex.Methods A total of 95 clinica1 isolates of ACB complex were collected from Daping Hospital from February to April 2014,identify by sequence analysis of 1 6S rRNA gene spacer region.Use VITEK-2compact automatic iden-tification of bacteria by susceptibility meter to detect the precise identification of all ACB complex group of drug sensitivity.Results Among all the 95 strains of ACB complex identification results were A.baumanni (81,85.26%),A.pittii(10,10.53%),A.noso-comialis (4,4.21%).A.baumannii to third generation cephalosporins,aminoglycosides and carbapenem antibiotic resistance in seri-ous condition,the sensitive rate was only about 20.00%.But A.pittii and A.nosocomialis had a high sensitivity rate to commonly used antibiotics.Conclusion VITEK-2 Compact automatic identification of bacteria susceptibility meter has limitations in identifica-tion of Acinetobacter,with analysis of 1 6S rRNA gene sequencing,the ACB complex could be accurately identified.There is signifi-cant difference in the composite group-resistant characteristics of each species,clinical infection is also various.
ABSTRACT
Objective To investigate the drug tolerance of Acinetobacter baumanni and Stenotrophomonas maltophilia . Methods The antimicrobial susceptibility tests for 275 isolates of Acinetobacter baumanni and 107 isolates of Stenotrophomonas maltophilia from 2000 to 2004 were measured by MicroScan WarkAway 96 The chemotherapeutic effects of 18 cases of sequent infection with Acinetobacter baumanni and Stenotrophomonas maltophilia was analyzed. Results The resistance of the two species of bacteria to twelve antibiotics increased obviously during the last five years, especially from 2000 to 2001. The resistant rate of Acinetobacter baumanni to Cefepime、Cefotaxime、Ceftazidime and Ceftriaxonewas was 20~50% in 2000, but raised to 70%~81% in 2004. For Acinetobacter baumanni to Amikacin、Amp/sulbac、Ciprofloxacin、Gentamicin、Tobramycin and Trimeth/Sulfa, the resistant rate was 20%~40% in 2000, while 63~86% in 2004. The lowest resistant rate was to Imipenem, only 7% or so. The resistant rate of Stenotrophomonas maltophilia to Ciprofloxacin、Ceftazidime、ceftriaxone and Tobramycin was 25%、50%、0% and 0%, respectively, in 2000, but in 2004 year, was 76%、76%、95% and 95%, respectively. Stenotrophomonas maltophilia showed a high drug tolerance to other antibiotics. Conclusion To strengthen the monitoring of the antibiotic resistance of Acinetobacter baumanni and Stenotrophomonas maltophilia and the monitoring of sequential infection in Acinetobacter baumanni and Stenotrophomonas maltophilia is very important for clinic so as to choose antibiotic rationally and improve curative effect